Anti-CD20 Discontinuation Versus Continuation in People Aged Over 50 With Non-Active Multiple Sclerosis.

Moukhine A, Rollot F, Casey R, Collongues N, Vukusic S, Mathey G, Dubessy A L, Ciron J, de Seze J, Ruet A, et al.